Go back

Ketamine-Assisted Psychotherapy: A Beacon of Hope for Workers Battling COVID-19-Related Burnout, PTSD, and More

Fighting at the forefront of healthcare within the acute care and trauma surgery environment, I have personally witnessed and endured the debilitating effects of burnout. The onset of the COVID-19 pandemic exacerbated these challenges exponentially. Prolonged shifts, inadequate staffing, and a healthcare system in disarray create a recipe for employee dissatisfaction and burnout.

However, it's important to note that the pandemic's overwhelming demands have impacted more than just healthcare workers. Countless stories can be heard of individuals across various fields struggling with the relentless pressures of the workforce, prompting them to question their career satisfaction and reevaluate life choices. Throughout the pandemic, many choose to pivot their focus towards leading a life of higher quality and less stress at work.

This shift in outlook coincided with the burgeoning use of psychedelics, including ketamine, to treat mental illness such as Post-Traumatic Stress Disorder or PTSD, depression, and anxiety that result from an unsteady work-life balance and is something that strikes a chord with me personally.

In this discussion, we will delve into the details of the cohort-based case report titled "Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD,” and how its compelling results may point to the future of how ketamine and psychedelic-assisted therapy may be applied to improve the workforce. Moreover, we will explore how its insights extend beyond healthcare professionals, offering relevance to a broader range of individuals impacted by the aftermath of the pandemic's devastating effects.

Ketamine-Assisted Therapy: A Holistic Approach in Times of Crisis

In the midst of a global pandemic and an escalating mental health crisis, this study has shed light on a potential lifeline for frontline healthcare workers struggling with mental health conditions. The study explores the transformative power of ketamine-assisted therapy within a group-oriented community of practice (CoP) framework. This innovative approach offers a glimmer of hope to those with depression, anxiety, and PTSD, promising a path to healing and recovery.

The Group-Oriented Community of Practice Model

At the heart of the study is the CoP model, an interdisciplinary team comprising medical professionals, therapists, cultural experts, and Indigenous Elders. This holistic approach ensures comprehensive care, addressing not only the psychological dimensions of trauma but also the cultural and somatic aspects. By uniting a diverse range of experts, the CoP model creates a safe and supportive environment for healthcare providers to share their experiences, fostering congruence and a sense of coherence.

The treatment program extends over a span of 12 weeks, combining CoP sessions and three ketamine-assisted therapy sessions. The CoP sessions are designed to cultivate somatic awareness, trauma-informed care, and authentic expression. By encouraging participants to tap into their inner resources, these sessions lay the foundation for the transformative experiences that follow.

The ketamine-assisted therapy sessions, guided by therapist and clinician, take participants on a journey within. The non-ordinary states of consciousness induced by ketamine allow individuals to confront traumatic memories and disempowering beliefs, opening the door to healing and growth. The study reports remarkable outcomes from the program, highlighting significant improvements in depression, PTSD, generalized anxiety disorder, and work-life functionality. This empirical evidence is further bolstered by the moving feedback from participants, who share tales of profound personal transformation:

“The trust that was felt in our group occurred in the first session and has increased every week. I realized that I don’t need to know their stories nor do they need to know mine to have a strong trusting relationship. I love that our facilitators are also sharing with us, they continue to work on themselves through this process.”

Results and Future Prospects

The results comparing baseline and outcome measures (assessed within 1–2 weeks after the 12-week program's completion) exhibited clinical significance, highlighting substantial enhancements in depression, post-traumatic stress disorder, generalized anxiety disorder, and work/life functionality. To summarize, 91% witnessed improvements in generalized anxiety, 79% experienced betterment in depression, individuals previously screening positive for PTSD shifted to negative screening by 86%, and a noteworthy 92% achieved significant improvements in life and work functionality.

Ketamine and Psychedelic-Assisted Therapies as a Benefit

One other trend to improve workforce health and productivity is by offering employees ketamine-assisted therapy as an employee benefit. Enthea is one such company striving to enhance accessibility to psychedelic-assisted therapies through employer-provided health benefit coverage. Enthea is a mental health organization committed to ensuring safe and affordable access to psychedelic-assisted therapy, with an initial focus on ketamine therapy. It's inspiring to witness the prospect of innovative mental health therapies as part of employee health benefits.

“As A Public Benefit Corporation, We Are Prioritizing The Removal Of Health Equity Obstacles That Impede People From Receiving Impactful Mental Healthcare Services.” -Enthea
A cartoon illustration of a therapist leading a psychedelic assisted psychotherapy session using mushrooms

Bridging the Gap: Extending Ketamine-Assisted Therapy's Reach Beyond Healthcare

As we navigate the continually evolving landscape of mental health treatment, the findings from this study can be extrapolated to encompass other professionals, not limited to healthcare, who also experience work-related burnout. This study underscores the importance of integrating a team approach into the healing process associated with ketamine and psychedelic therapy.

At Innerbloom Ketamine Therapy, we also understand the significance of adopting a multidisciplinary approach, often involving a team, with a holistic perspective and a strong focus on aftercare and sustained integration long after the ketamine infusion process concludes. By incorporating a multimodal and multidisciplinary approach alongside cutting-edge science, this model establishes a defense against the growing tide of mental health challenges affecting our global community.

Serving as a source of hope, this groundbreaking approach not only addresses the burdens of COVID-19-related burnout and PTSD faced by healthcare providers but also offers a transformative path to healing and renewal for a wider range of people in the workforce.

Keep reading

Disclaimer: All content on this website, including (but not limited to) this statement, news, blog post, article, testimonial, or FAQ is not medical advice and should not be considered as such. This website cannot diagnose or treat any medical condition. Only a licensed medical professional who is familiar with you and your medical history can do that. Therefore, we cannot be responsible or liable for any actions taken by those who access our website or rely on its content. Please refer to the Terms & Conditions for more information.